Sterile protection against human malaria by chemoattenuated PfSPZ vaccine

Nature

Volumn 542, Issue 7642, 2017, Pages 445-449

  Mordmüller, Benjamin ^a   Surat, Güzin ^a   Lagler, Heimo ^a,b   Chakravarty, Sumana ^c   Ishizuka, Andrew S ^d   Lalremruata, Albert ^a   Gmeiner, Markus ^a   Campo, Joseph J ^e   Esen, Meral ^a   Ruben, Adam J ^c   Held, Jana ^a   Calle, Carlos Lamsfus ^a   Mengue, Juliana B ^a   Gebru, Tamirat ^a   Ibáñez, Javier ^a   Sulyok, Mihály ^a   James, Eric R ^c   Billingsley, Peter F ^c   Natasha, Kc ^c,f   Manoj, Anita ^c   Murshedkar, Tooba ^c   Gunasekera, Anusha ^c   Eappen, Abraham G ^c   Li, Tao ^c   Stafford, Richard E ^c   Li, Minglin ^c,f   Felgner, Phil L ^g   Seder, Robert A ^d   Richie, Thomas L ^c   Sim, B Kim Lee ^c,f   Hoffman, Stephen L ^c   Kremsner, Peter G ^a   more..

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c SANARIA INC   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e Antigen Discovery Inc   (United States)

^f Protein Potential LLC   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; MALARIA VACCINE; PFSPZ VACCINE; UNCLASSIFIED DRUG; CHLOROQUINE; PROTOZOON ANTIBODY;

CELLS AND CELL COMPONENTS; DOSE-RESPONSE RELATIONSHIP; IMMUNE RESPONSE; IMMUNIZATION; INOCULATION; MALARIA; MEMORY; MOSQUITO; PEPTIDE; VACCINATION; VACCINE;

ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; FLOW CYTOMETRY; HUMAN; IMMUNIZATION; IMMUNOFLUORESCENCE TEST; MALARIA CONTROL; MASS IMMUNIZATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ADOLESCENT; ADULT; BLOOD; CLASSIFICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MALARIA, FALCIPARUM; MIDDLE AGED; NORMAL HUMAN; PARASITOLOGY; RANDOMIZED CONTROLLED TRIAL; SPOROZOITE; T LYMPHOCYTE; TIME FACTOR; YOUNG ADULT;

PLASMODIUM FALCIPARUM;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; CHLOROQUINE; DOUBLE-BLIND METHOD; HEALTHY VOLUNTEERS; HUMANS; IMMUNOLOGIC MEMORY; MALARIA VACCINES; MALARIA, FALCIPARUM; MIDDLE AGED; PLASMODIUM FALCIPARUM; SPOROZOITES; T-LYMPHOCYTES; TIME FACTORS; VACCINES, ATTENUATED; YOUNG ADULT;

EID: 85014715170     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature21060     Document Type: Article

References (45)

1. malERA Consultative Group on Vaccines. A research agenda for malaria eradication: vaccines. PLoS Med. 8, e1000398 (2011).
2. Clyde, D. F., Most, H., McCarthy, V. C. & Vanderberg, J. P. Immunization of man against sporozite-induced falciparum malaria. Am. J. Med. Sci. 266, 169-177 (1973).
3. Rieckmann, K. H., Carson, P. E., Beaudoin, R. L., Cassells, J. S. & Sell, K. W. Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 68, 258-259 (1974).
4. Hoffman, S. L. et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185, 1155-1164 (2002).
5. Seder, R. A. et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341, 1359-1365 (2013).
6. Ishizuka, A. S. et al. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat. Med. 22, 614-623 (2016).
7. Bijker, E. M. et al. Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites. J. Infect. Dis. 210, 1605-1615 (2014).
8. Bijker, E. M. et al. Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. Proc. Natl Acad. Sci. USA 110, 7862-7867 (2013).
9. Roestenberg, M. et al. Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 361, 468-477 (2009).
10. Roestenberg, M. et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 377, 1770-1776 (2011).
11. Bijker, E. M. et al. Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial. PLoS One 9, e112910 (2014).
12. Gomez-Perez, G. P. et al. Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naive volunteers: effect of injection volume and dose on infectivity rates. Malar. J. 14, 306 (2015).
13. Mordmuller, B. et al. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres. Malar. J. 14, 117 (2015).
14. Bastiaens, G. J. et al. Safety, immunogenicity, and protective efficacy of intradermal immunization with aseptic, purified, cryopreserved Plasmodium falciparum sporozoites in volunteers under chloroquine prophylaxis: a randomized controlled trial. Am. J. Trop. Med. Hyg. 94, 663-673 (2016).
15. Beaudoin, R. L., Strome, C. P. A., Mitchell, F. & Tubergen, T. A. Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen. Exp. Parasitol. 42, 1-5 (1977).
16. Guerin-Marchand, C. et al. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 329, 164-167 (1987).
17. Orito, Y. et al. Liver-specific protein 2: a Plasmodium protein exported to the hepatocyte cytoplasm and required for merozoite formation. Mol. Microbiol. 87, 66-79 (2013).
18. Tarun, A. S. et al. A combined transcriptome and proteome survey of malaria parasite liver stages. Proc. Natl Acad. Sci. USA 105, 305-310 (2008).
19. Richie, T. L. et al. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines. Vaccine 33, 7452-7461 (2015).
20. Epstein, J. E. et al. Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity. Science 334, 475-480 (2011).
21. Suhrbier, A., Winger, L. A., Castellano, E. & Sinden, R. E. Survival and antigenic profile of irradiated malarial sporozoites in infected liver cells. Infect. Immun. 58, 2834-2839 (1990).
22. Behet, M. C. et al. Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum. Malar. J. 13, 136 (2014).
23. Schofield, L. et al. Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330, 664-666 (1987).
24. Weiss, W. R., Sedegah, M., Beaudoin, R. L., Miller, L. H. & Good, M. F. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl Acad. Sci. USA 85, 573-576 (1988).
25. Doolan, D. L. & Hoffman, S. L. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165, 1453-1462 (2000).
26. Belnoue, E. et al. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol. 172, 2487-2495 (2004).
27. Weiss, W. R. & Jiang, C. G. Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. PLoS One 7, e31247 (2012).
28. Fernandez-Ruiz, D. et al. Liver-resident memory CD8+ T cells form a front-line defense against malaria liver-stage infection. Immunity 45, 889-902 (2016).
29. Schats, R. et al. Heterologous protection against malaria after immunization with Plasmodium falciparum sporozoites. PLoS One 10, e0124243 (2015).
30. Egan, J. E. et al. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am. J. Trop. Med. Hyg. 49, 166-173 (1993).
31. Epstein, J. E. et al. Protection against Plasmodium falciparum malaria by PfSPZ Vaccine. JCI Insight 2, e89154 (2017).
32. Lyke, K. et al. PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous malaria challenge. Proc. Natl Acad. Sci. USA (in the press).
33. Sissoko, M. S. et al. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed Malian adults: a randomised, double-blind trial. Lancet Infect Dis. (in the press).
34. Roestenberg, M. et al. Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites. Am. J. Trop. Med. Hyg. 88, 5-13 (2013).
35. Sahu, T. et al. Chloroquine neither eliminates liver stage parasites nor delays their development in a murine chemoprophylaxis vaccination model. Front. Microbiol. 6, 283 (2015).
36. Fairley, N. H. Chemotherapeutic suppression and prophylaxis in malaria. Trans. R. Soc. Trop. Med. Hyg. 38, 311-365 (1945).
37. Planche, T. et al. Comparison of methods for the rapid laboratory assessment of children with malaria. Am. J. Trop. Med. Hyg. 65, 599-602 (2001).
38. Kamau, E., Alemayehu, S., Feghali, K. C., Saunders, D. & Ockenhouse, C. F. Multiplex qPCR for detection and absolute quantification of malaria. PLoS One 8, e71539 (2013).
39. Bustin, S. A. et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611-622 (2009).
40. R Core Team. R: A Language and Environment for Statistical Computing. (2015).
41. Roederer, M., Nozzi, J. L. & Nason, M. C. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79, 167-174 (2011).
42. Sattabongkot, J. et al. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am. J. Trop. Med. Hyg. 74, 708-715 (2006).
43. Felgner, P. L. et al. Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis. Sci. Rep. 3, 3549 (2013).
44. Davies, D. H. et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl Acad. Sci. USA 102, 547-552 (2005).
45. Lamoreaux, L., Roederer, M. & Koup, R. Intracellular cytokine optimization and standard operating procedure. Nat. Protocols 1, 1507-1516 (2006).